Real-life dosing with second-generation antipsychotics

J Clin Psychiatry. 2005 Dec;66(12):1610-1. doi: 10.4088/jcp.v66n1218.
No abstract available

MeSH terms

  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / therapeutic use
  • Clinical Trials, Phase IV as Topic
  • Drug Administration Schedule
  • Drug Approval
  • Humans
  • Maximum Tolerated Dose
  • Product Surveillance, Postmarketing
  • Psychotic Disorders / drug therapy*
  • Randomized Controlled Trials as Topic
  • Schizophrenia / drug therapy
  • Schizophrenic Psychology
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Antipsychotic Agents